Large drug makers scrambling to increase R&D spending

Published: 2012-02-20 06:58:00

Updated: 2012-02-20 06:58:00

Major pharmaceutical firms seek to expand their corporate investment in research and development (R&D) as part of efforts to be selected in one of innovative drug firms.

The Ministry of Health and Welfare unveiled a set of plans in January to nurture 12 globally competitive pharmaceutical comp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK